ID Name Structure References (top 5) Molecular Target(s)
1ID:6664
VITAMIN D2


NSC#:62792
Aldrich#:271586
Aldrich#:95220
Aldrich#:E1007
Aldrich#:E5750
Aldrich#:E9007
Aldrich#:R204331
FDA approved!!!

Freqency:
in 1 ingredients:

  • 52
  • in 8 recipes:

  • 2
  • 12
  • 100
  • 125
  • 205
  • 217
  • 271
  • 380

  • Properties
    C28H44O    396.65





    1:  Arieff AI, Massry SG.
    Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
    J Clin Invest.    impact factor:   10.921
    1974;  53(2): 387-92

    2:  Weber K, Goldberg M, Stangassinger M, Erben RG.
    1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    J Bone Miner Res.    impact factor:   6.477
    2001;  16(4): 639-51

    3:  Jensen LB, Kollerup G, Quaade F, Sorensen OH.
    Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation.
    J Bone Miner Res.    impact factor:   6.477
    2001;  16(1): 141-7

    4:  Finch JL, Dusso AS, Pavlopoulos T, Slatopolsky EA.
    Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells.
    J Am Soc Nephrol.    impact factor:   6.182
    2001;  12(7): 1468-74

    5:  Brown AJ, Finch J, Takahashi F, Slatopolsky E.
    Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment.
    J Am Soc Nephrol.    impact factor:   6.182
    2000;  11(11): 2088-94

     
    Time used: 109 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005